Matinas Biopharma Statistics
NYSE: MTNBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.83+0.06 (+2.17%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Matinas Biopharma by the numbers
Matinas Biopharma has a market capitalization of $2.8 million based on 979.52K shares outstanding. With trailing EPS of $-17.55, Matinas Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.7% below its 50-day average and 63.1% below its 200-day average.
Average daily trading volume is 405.99K shares, or about $1.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MTNB valuation vs. peer median
| Metric | MTNB | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.77M | $2.73M | +1% |
| Avg. volume | 405.99K | 239.53K | +69% |
Peer median across 8 companies: SPRC, GOVX, ELAB, SILO, PRFX, REVB, PPBT, TCRT.
Valuation
- Market cap
- $2.77M
- EPS (TTM)
- $-17.55
- Shares outstanding
- 979.52K
Price and trading
- Previous close
- 2.77
- Open
- 2.73
- Day range
- 2.62 – 2.85
- 52-week range
- 2.27 – 28.95
- Beta
- —
- Volume
- 136.16K
- Average volume
- 405.99K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2025
Additional statistics
- Market Cap
- 2.77M
- Forward Pe
- -0.94
- Eps
- -17.55
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 28.95
- Week52 Low
- 2.27
- Avg Volume
- 405.99K
- Shares Outstanding
- 979.52K
- Ma50
- 3.14
- Ma200
- 7.66
- Earnings Date
- Aug 13, 2025
- Pct From52w High
- -90.22%
- Pct From52w Low
- 24.94%